ArticleRevista brasileira de enfermagem2026
Suicide, quality of life, and psychotropic medication use in women with breast cancer.
Article in Revista brasileira de enfermagem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesto identify factors associated with suicide risk, quality of life, and psychotropic medication use among women with breast cancer treated at an oncology hospital.
methodsa cross-sectional, descriptive, correlational study with a quantitative approach was conducted in the mastology outpatient clinic of a specialized oncology hospital. A total of 102 women participated and completed specific questionnaires. Linear and logistic regression models were used to assess the association between psychotropic use, suicide risk, and quality of life.
results15.7% of participants presented suicide risk, and 23.6% used psychotropic medications, mainly benzodiazepines and antidepressants. Non-Catholic women and those in stage III showed higher psychotropic consumption. Quality of life was lower in physical and psychological domains, and psychotropic use was associated with poorer scores across all domains.
conclusionsthe findings highlight the importance of early identification of suicide risk and the development of personalized emotional support strategies for women with breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.